Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 4;21(5):1750.
doi: 10.3390/ijms21051750.

Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives

Affiliations
Review

Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives

Costin Vlad Anastasiu et al. Int J Mol Sci. .

Abstract

Background: Early and accurate diagnosis of endometriosis is crucial for the management of this benign, yet debilitating pathology. Despite the advances of modern medicine, there is no common ground regarding the pathophysiology of this disease as it continues to affect the quality of life of millions of women of reproductive age. The lack of specific symptoms often determines a belated diagnosis. The gold standard remains invasive, surgery followed by a histopathological exam. A biomarker or a panel of biomarkers is easy to measure, usually noninvasive, and could benefit the clinician in both diagnosing and monitoring the treatment response. Several studies have advanced the idea of biomarkers for endometriosis, thereby circumventing unnecessary invasive techniques. Our paper aims at harmonizing the results of these studies in the search of promising perspectives on early diagnosis.

Methods: We selected the papers from Google Academic, PubMed, and CrossRef and reviewed recent articles from the literature, aiming to evaluate the effectiveness of various putative serum and urinary biomarkers for endometriosis.

Results: The majority of studies focused on a panel of biomarkers, rather than a single biomarker and were unable to identify a single biomolecule or a panel of biomarkers with sufficient specificity and sensitivity in endometriosis.

Conclusion: Noninvasive biomarkers, proteomics, genomics, and miRNA microarray may aid the diagnosis, but further research on larger datasets along with a better understanding of the pathophysiologic mechanisms are needed.

Keywords: angiogenesis; biomarker; cytokines; endometriosis; urinary biomarkers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Putative noninvasive biomarkers for endometriosis [12].
Figure 2
Figure 2
Angiogenesis process—In endometriosis, the central role in pathophysiological mechanisms is attributed to macrophages. These cells increase the intranuclear expression of vascular endothelial growth factor (VEGF) and cyclooxigenase 2 (COX-2) genes, leading to increased angiogenesis and an inflammatory environment [58].

References

    1. Bratila E., Comandasu D.-E., Coreleuca C., Cirstoiu M., Bohiltea R., Mehedintu C., Vladareanu S., Berceanu C. Gatrointestinal Symptoms in Endometriosis Correlated With the Disease Stage. [(accessed on 27 October 2019)];2016 Available online: https://www.researchgate.net/publication/312552546_Gastrointestinal_symp....
    1. Giudice L.C., Kao L.C. Endometriosis. Lancet. 2004;364:1789–1799. doi: 10.1016/S0140-6736(04)17403-5. - DOI - PubMed
    1. Moga M.A., Balan A., Dimienescu O.G., Burtea V., Dragomir R.M., Anastasiu V.C. Circulating miRNAs as biomarkers for endometriosis and endometriosis-related ovarian cancer—An overview. J. Clin. Med. 2019;8:735. doi: 10.3390/jcm8050735. - DOI - PMC - PubMed
    1. Bulletti C., Coccia M.E., Battistoni S., Borini A. Endometriosis and infertility. J. Assist. Reprod. Genet. 2010;27:441–447. doi: 10.1007/s10815-010-9436-1. - DOI - PMC - PubMed
    1. Argawal S.K., Chapron C., Giudice L.C., Laufer M.R., Lyland N., Missmer S.A., Singh S.S., Taylor H.S. Clinical diagnosis of endometriosis: A call to action. Am. J. Obstet. Gynecol. 2019;220:354.e1–354.e12. doi: 10.1016/j.ajog.2018.12.039. - DOI - PubMed